11/18/2024
8:06 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:32 PM | Aura Biosciences (Subject)
Hopkins Janet Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:50 PM | Aura Biosciences (Subject)
Lundbeckfond Invest A/S (Filed by)
| Form SC 13G/A | |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Aura Biosciences (Subject)
| Form SC 13G/A | |
10/29/2024
7:33 PM | Aura Biosciences (Subject)
Feder Julie B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:33 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:38 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/29/2024
7:23 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
7:28 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
7:18 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
5:06 PM | Aura Biosciences (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/21/2024
5:23 PM | Aura Biosciences (Issuer)
Feder Julie B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
7:08 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:21 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:21 PM | Aura Biosciences (Subject)
Feder Julie B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
4:10 PM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
8:22 PM | Aura Biosciences (Subject)
Plavsic Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
8:25 PM | Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:08 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:05 PM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:50 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:05 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:10 AM | Aura Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/14/2024
3:37 PM | Aura Biosciences (Filer)
| Form 10-K/A | |
06/14/2024
3:42 PM | Aura Biosciences (Filer)
| Form DEFA14A | |
05/09/2024
6:05 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:10 AM | Aura Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/07/2024
11:15 PM | Aura Biosciences (Filer)
| Form EFFECT | |
04/04/2024
3:10 PM | Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
6:59 AM | Aura Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024
7:12 AM | Aura Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/27/2024
6:11 AM | Aura Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
6:05 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
3:22 PM | Aura Biosciences (Subject)
Rich Cadmus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
3:57 PM | Aura Biosciences (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
6:54 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Aura Biosciences (Subject)
| Form SC 13G/A | |
01/24/2024
3:20 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:31 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
3:29 PM | Aura Biosciences (Subject)
Rich Cadmus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
3:30 PM | Aura Biosciences (Subject)
Rich Cadmus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
